Agilent Technologies Inc (A) Stock Analysis
Verdict: WATCH (do not buy)
Strong CrossLab recurring revenue drives mid-single-digit growth, but rich 29.4x P/E limits short-term upside beyond $170.
Investment score: 59/100
Analysis as of
Is Agilent Technologies Inc stock worth reviewing? AI model thesis
The model evaluates Agilent as a high-quality life sciences tool provider trading near peak valuation multiples. Strong balance sheet strength and high gross margins (53.92%) justify a premium, but a 29.37x P/E and modest 9.1% consensus target upside justify a HOLD recommendation.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 78/100 (weight 15%)
- Technical Momentum: 75/100 (weight 15%)
- Earnings Quality: 65/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 50/100 (weight 15%)
Agilent Technologies Inc opportunities and risks
What speaks for A
- Agilent CrossLab segment delivers sticky recurring revenue via consumables and services
What speaks against A
- Geopolitical tension and reduced instrument capital expenditure in China market
Frequently asked questions about Agilent Technologies Inc (A)
Is A stock a good investment?
The cached TradeMates AI model rates Agilent Technologies Inc as WATCH (do not buy) with an investment score of 59/100. The model evaluates Agilent as a high-quality life sciences tool provider trading near peak valuation multiples. Strong balance sheet strength and high gross margins (53.92%) justify a premium, but a 29.37x P/E and modest 9.1% consensus target upside justify a HOLD recommendation. This is algorithmic model output, not personal investment advice.
Is A stock a buy?
The TradeMates model verdict for A is WATCH (do not buy) with an investment score of 59/100. Treat this as a model signal to review, not a personal buy recommendation.